Co-op Feature: Om Bhatt

In this edition of The Frequency’s co-op feature, we focus on another unique co-op opportunity. Om Bhatt is currently in his second year in the iBioMed program, pursuing a degree in Health, Engineering Science and Entrepreneurship. In this article he shares with us some experiences he has had during his co-op, how it has changed his approach to learning, and some tips he has for other students planning to enter the workforce.

How did you get this opportunity/position?

Networking, networking, and more networking! I met the CEO of Profound Medical in the unlikeliest of places: my sister’s dance class. We initially struck up a conversation to pass the time and it flowed naturally. We discussed some of my academic endeavours and I began to explain to him a bit about the innovative projects I worked on in the iBioMed program. Following our discussion, he gave me his business card and told me to keep in touch. I followed up with him via email and to my delight, he set me up with an interview! During this interview, we discussed some of my prior experiences, assisting in clinical research with Dr. Michelle Ghert, Professor in the Division of Orthopaedic Surgery at McMaster University and my collaborative projects in the iBioMed program. The moral of the story is that you never know when or where you will run into someone that can help you in your career.

What kind of projects does the company you are working for specialize in?

The company is called Profound Medical Inc. Profound Medical is an innovative health technology company that develops customizable, incision-free therapies, combining real-time magnetic resonance imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. We aim to improve lives for patients all over the world, treating conditions such as intermediate stage prostate cancer, localized radio-recurrent prostate cancer, retention and hematuria palliation in locally advanced prostate cancer, and the transition zone in large volume benign prostatic hyperplasia (BPH) with our TULSA-PRO® technology. We are also commercializing Sonalleve®, an innovative therapeutic platform th